Furthermore, targeting caspase-7 in SW480 cells led to increased cell viability and decreased apoptosis in the presence of SREBP1 downregulation, thereby resulting in decreased sensitivity to chemotherapy drugs, suggesting that targeting SREBP1 sensitizes CRC cells to chemotherapy by caspase-7 upregulation. Here, SREBF1 is linked to colorectal carcinoma.